Talkspace, Inc. (“Talkspace” or the “Company”) (NASDAQ: TALK),
today reported fourth quarter and full year 2024 financial results.
|
|
|
|
Three Months Ended December 31, 2024 |
|
Year Ended December 31, 2024 |
|
|
|
|
|
Unaudited |
|
Results |
|
% Variance from Prior Year |
|
Results |
|
% Variance from Prior Year |
(In thousands
unless otherwise noted) |
|
|
|
|
|
|
|
|
Number of eligible
lives at year end (in millions) |
|
179.4 |
|
37% |
|
179.4 |
|
37% |
Number of
completed Payor sessions during the period |
|
330.0 |
|
32% |
|
1,229.2 |
|
45% |
Number of Consumer
active members at year end |
|
7.2 |
|
(38)% |
|
7.2 |
|
(38)% |
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
$48,720 |
|
15% |
|
$187,593 |
|
25% |
Gross profit |
|
$21,533 |
|
3% |
|
$85,836 |
|
15% |
Gross margin
% |
|
44.2% |
|
|
|
45.8% |
|
|
Operating
expenses |
|
$20,964 |
|
(11)% |
|
$90,333 |
|
(7)% |
Net income |
|
$1,214 |
|
* |
|
$1,148 |
|
* |
Adjusted EBITDA
(1) |
|
$2,659 |
|
* |
|
$6,962 |
|
* |
Cash and cash
equivalents at year end |
|
$76,692 |
|
— |
|
$76,692 |
|
— |
Short-term
marketable securities |
|
$41,118 |
|
— |
|
$41,118 |
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
* Percentage not
meaningful. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Adjusted EBITDA is a
non-GAAP financial measure. For a definition of the measure and a
reconciliation to the most direct comparable GAAP measure, see
“Reconciliation of GAAP Results to Non-GAAP Results.” |
|
|
|
“We closed out 2024 with a strong fourth quarter, delivering
revenue and adjusted EBITDA growth as expected. We continued to
broaden our reach, drive awareness and adoption, enhance the
provider and member experience, and deliver high-quality care. I’m
proud of all that Talkspace has accomplished this year to build a
sustainable, profitable business,” said Dr. Jon Cohen, CEO of
Talkspace.
Dr. Cohen continued, “Over the last three years, we've undergone
a significant strategic shift, focusing on the payor market and
growing our total covered lives to nearly 200 million. We've
leveraged our well-known brand to drive awareness of Talkspace as
an affordable way to access care for not just commercially insured
adults, but also teens, seniors, and active members of the
military. Talkspace has established a clear competitive advantage
in the marketplace with the comprehensive nature of our solution,
and we remain dedicated to meeting the escalating demand for
accessible, high-quality behavioral health services in the
U.S.”
Fourth Quarter 2024 Key Performance Metrics
- Revenue increased 15% over the prior-year period to $48.7
million, driven by a 34% year-over-year increase in Payor revenue
and a 7% year-over-year increase in Direct to Enterprise (“DTE”)
revenue; partially offset by a 35% year-over-year decline in
Consumer revenue.
- Gross profit increased 3% over the prior-year period to $21.5
million, and gross margin declined to 44.2% from 49.4% in the
prior-year period, driven by a shift in revenue mix towards
Payor.
- Operating expenses were $21.0 million, a decrease of 11%
year-over-year.
- Net income was $1.2 million, an improvement from $(1.3) million
net loss in the fourth quarter of 2023, primarily driven by an
increase in revenues and a decrease in operating expenses,
partially offset by an increase in cost of revenues.
- Adjusted EBITDA was $2.7 million, an improvement from $(0.3)
million adjusted EBITDA loss in the fourth quarter of 2023,
primarily driven by an increase in revenues and a decrease in
operating expenses, partially offset by an increase in cost of
revenues.
Full Year 2024 Key Performance
Metrics
- Revenue increased 25% over the prior-year to $187.6 million,
driven by a 54% year-over-year increase in Payor revenue and a 14%
year-over-year increase in DTE revenue; partially offset by a 30%
year-over-year decline in Consumer revenue.
- Gross profit increased 15% over the prior-year to $85.8
million, and gross margin declined to 45.8% from 49.6% in the
prior-year, driven by a shift in revenue mix towards Payor.
- Operating expenses were $90.3 million, a decrease of 7%
year-over-year.
- Net income was $1.1 million, an improvement from $(19.2)
million net loss in 2023, primarily driven by an increase in
revenues and a decrease in operating expenses, partially offset by
an increase in cost of revenues.
- Adjusted EBITDA was $7.0 million, an improvement from $(13.5)
million adjusted EBITDA loss in 2023, primarily driven by an
increase in revenues and a decrease in operating expenses,
partially offset by an increase in cost of revenues.
Financial Guidance
The following guidance is based on current
market conditions and expectations and the information available to
the Company today. For 2025, Talkspace expects:
- Revenue to be in the range of $220 million to $235 million
- Adjusted EBITDA to be in the range of $14 million to $20
million
Conference Call, Presentation Slides, and Webcast
Details
The Fourth Quarter 2024 earnings conference call
and webcast will be held Thursday, February 20, 2025, at 8:30 a.m.
E.T. The conference call will be available via audio webcast at
investors.talkspace.com and can also be accessed by dialing (888)
596-4144 for U.S. participants, or +1 (646) 968-2525 for
international participants, and referencing participant code
1149251. A replay will be available shortly after the call’s
completion and remain available for approximately 90 days.
About Talkspace
Talkspace (NASDAQ: TALK) is a leading virtual
behavioral healthcare provider committed to helping people lead
healthier, happier lives through access to high-quality mental
healthcare. At Talkspace, we believe that mental healthcare is core
to overall health and should be available to everyone.
Talkspace pioneered the ability to text with a
licensed therapist from anywhere and now offers a comprehensive
suite of mental health services, including therapy for individuals,
teens, and couples, as well as psychiatric treatment and medication
management (18+). With Talkspace’s core therapy offerings, members
are matched with one of thousands of licensed therapists within
days and can engage in live video, audio, or chat sessions, and/or
unlimited asynchronous text messaging sessions.
All care offered at Talkspace is delivered
through an easy-to-use, fully-encrypted web and mobile platform
that meets HIPAA, federal, and state regulatory requirements. More
than 179 million Americans have access to Talkspace through their
health insurance plans, employee assistance programs, our
partnerships with leading healthcare companies, or as a free
benefit through their employer, school, or government agency.
For more information, visit
www.talkspace.com.
For Investors:ICR
WestwickeTalkspaceIR@westwicke.com
For Media:John KimSKDK(310)
997-5963jkim@skdknick.com
Forward Looking Statements
This press release contains certain
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, as amended. All
statements contained in this press release that do not relate to
matters of historical fact should be considered forward-looking,
including statements regarding our financial condition, anticipated
financial performance, achieving profitability, business strategy
and plans, market opportunity and expansion and objectives of our
management for future operations. These forward-looking statements
generally are identified by the words “anticipate,” “believe,”
“contemplate,” “continue,” “could,” “estimate,” “expect,”
“forecast,” “future,” “intend,” “may,” “might,” “opportunity,”
“plan,” “possible,” “potential,” “predict,” “project,” “should,”
“strategy,” “strive,” “target,” “will,” or “would,” the negative of
these words or other similar terms or expressions. The absence of
these words does not mean that a statement is not forward-looking.
Forward-looking statements are predictions, projections and other
statements about future events that are based on current
expectations and assumptions and, as a result, are subject to risks
and uncertainties. Many important factors could cause actual future
events to differ materially from the forward-looking statements in
this press release, including but not limited to: (i) rapid
technological change in our industry; (ii) our ability to secure
clients' contract renewals; (iii) our ability to maintain and
expand our network of therapists, psychiatrists and other
providers; (iv) a decline in the prevalence of enterprise-sponsored
healthcare or the emergence of new technologies may adversely
impact our DTE business; (v) if our or our vendors’ security
measures fail or are breached; (vi) changes in healthcare laws,
regulations or trends and our ability to operate in the heavily
regulated healthcare industry; and (vii) and the other factors,
risks and uncertainties described under the caption “Risk Factors”
in our most recent Annual Report on Form 10-K filed with the
Securities and Exchange Commission (“SEC”) on March 13, 2024,
subsequent quarterly reports on Form 10-Q and our other documents
filed from time to time with the SEC. These filings identify and
address other important risks and uncertainties that could cause
actual events and results to differ materially from those contained
in the forward-looking statements. Forward-looking statements speak
only as of the date they are made. Readers are cautioned not to put
undue reliance on forward-looking statements, and we assume no
obligation and do not intend to update or revise these
forward-looking statements, whether as a result of new information,
future events, or otherwise unless required to do so under
applicable law. We do not give any assurance that we will achieve
our expectations.
Talkspace, Inc.Consolidated Statements of
Income |
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
Year Ended December 31, |
|
|
|
|
|
|
2024 |
|
2023 |
|
% Change |
|
2024 |
|
2023 |
|
% Change |
(in thousands,
except percentages, share and per share data) |
|
Unaudited |
|
Unaudited |
|
|
|
Unaudited |
|
|
|
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
Payor revenue |
|
$33,847 |
|
$25,362 |
|
33.5 |
|
$124,339 |
|
$80,823 |
|
53.8 |
DTE revenue |
|
9,555 |
|
8,897 |
|
7.4 |
|
38,466 |
|
33,614 |
|
14.4 |
Consumer revenue |
|
5,318 |
|
8,159 |
|
(34.8) |
|
24,788 |
|
35,608 |
|
(30.4) |
Total revenue |
|
48,720 |
|
42,418 |
|
14.9 |
|
187,593 |
|
150,045 |
|
25.0 |
Cost of
revenues |
|
27,187 |
|
21,447 |
|
26.8 |
|
101,757 |
|
75,665 |
|
34.5 |
Gross profit |
|
21,533 |
|
20,971 |
|
2.7 |
|
85,836 |
|
74,380 |
|
15.4 |
Operating
expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
2,256 |
|
3,867 |
|
(41.7) |
|
10,510 |
|
17,571 |
|
(40.2) |
Clinical operations, net |
|
1,740 |
|
1,478 |
|
17.7 |
|
6,542 |
|
6,159 |
|
6.2 |
Sales and marketing |
|
12,039 |
|
12,846 |
|
(6.3) |
|
50,654 |
|
52,544 |
|
(3.6) |
General and administrative |
|
4,929 |
|
5,363 |
|
(8.1) |
|
22,627 |
|
21,315 |
|
6.2 |
Total operating
expenses |
|
20,964 |
|
23,554 |
|
(11.0) |
|
90,333 |
|
97,589 |
|
(7.4) |
Income (loss) from
operations |
|
569 |
|
(2,583) |
|
* |
|
(4,497) |
|
(23,209) |
|
80.6 |
Financial
(income), net |
|
(616) |
|
(1,330) |
|
(53.7) |
|
(5,739) |
|
(4,245) |
|
35.2 |
Income (loss)
before income taxes |
|
1,185 |
|
(1,253) |
|
* |
|
1,242 |
|
(18,964) |
|
* |
Income tax
(benefit) expense |
|
(29) |
|
53 |
|
* |
|
94 |
|
218 |
|
(56.9) |
Net income
(loss) |
|
$1,214 |
|
$(1,306) |
|
* |
|
$1,148 |
|
$(19,182) |
|
* |
Net income (loss)
per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$0.01 |
|
$(0.01) |
|
* |
|
$0.01 |
|
$(0.12) |
|
* |
Diluted |
|
$0.01 |
|
$(0.01) |
|
* |
|
$0.01 |
|
$(0.12) |
|
* |
Weighted average
shares used to compute net income (loss) per share: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
169,202,561 |
|
167,485,398 |
|
|
|
168,906,900 |
|
165,039,920 |
|
|
Diluted |
|
176,711,336 |
|
167,485,398 |
|
|
|
176,495,872 |
|
165,039,920 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Percentage not
meaningful. |
Talkspace, Inc.Consolidated Statements of
Comprehensive Income (Loss) |
|
|
|
|
Three Months Ended December 31, |
|
|
|
Year Ended December 31, |
|
|
|
|
|
2024 |
|
2023 |
|
% Change |
|
2024 |
|
2023 |
|
% Change |
|
|
|
Unaudited |
|
Unaudited |
|
|
|
Unaudited |
|
|
|
|
(in
thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
Net income
(loss) |
|
$1,214 |
|
$(1,306) |
|
* |
|
$1,148 |
|
$(19,182) |
|
* |
Other
comprehensive income: |
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized gains on marketable debt securities |
|
2 |
|
— |
|
100.0 |
|
2 |
|
— |
|
100.0 |
Total other
comprehensive income |
|
2 |
|
— |
|
100.0 |
|
2 |
|
— |
|
100.0 |
Total
comprehensive income (loss) |
|
$1,216 |
|
$(1,306) |
|
* |
|
$1,150 |
|
$(19,182) |
|
* |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* Percentage not
meaningful. |
|
|
|
|
|
|
|
|
|
|
Talkspace,
Inc.Consolidated Balance Sheets |
|
|
|
|
|
|
December 31, 2024 |
|
December 31, 2023 |
(in thousands) |
|
Unaudited |
|
|
ASSETS |
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
Cash and cash equivalents |
|
$76,692 |
|
$123,908 |
Marketable
securities |
|
41,118 |
|
— |
Accounts receivable, net |
|
9,643 |
|
10,174 |
Other current assets |
|
2,729 |
|
5,718 |
Total current assets |
|
130,182 |
|
139,800 |
Other long-term assets |
|
8,495 |
|
2,421 |
Total assets |
|
$138,677 |
|
$142,221 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
Accounts payable |
|
$7,710 |
|
$6,111 |
Accrued expenses and other current liabilities |
|
8,031 |
|
12,468 |
Deferred revenues |
|
3,282 |
|
3,069 |
Total current liabilities |
|
19,023 |
|
21,648 |
Warrant liabilities |
|
1,690 |
|
1,842 |
Other liabilities |
|
569 |
|
85 |
Total liabilities |
|
21,282 |
|
23,575 |
STOCKHOLDERS’ EQUITY: |
|
|
|
|
Common stock |
|
17 |
|
16 |
Additional paid-in capital |
|
386,612 |
|
389,014 |
Accumulated deficit |
|
(269,236) |
|
(270,384) |
Accumulated other comprehensive income |
|
2 |
|
— |
Total stockholders’ equity |
|
117,395 |
|
118,646 |
Total liabilities and stockholders’ equity |
|
$138,677 |
|
$142,221 |
Talkspace, Inc.Consolidated Statements of
Cash Flows |
|
|
|
Year Ended December 31, |
|
|
2024 |
|
2023 |
(in thousands) |
|
Unaudited |
|
|
Cash flows from
operating activities: |
|
|
|
|
Net income (loss) |
|
$1,148 |
|
$(19,182) |
Adjustments to reconcile net
income (loss) to net cash provided by (used in) operating
activities: |
|
|
|
|
Depreciation and amortization |
|
859 |
|
1,196 |
Stock-based compensation |
|
9,173 |
|
8,395 |
Remeasurement of warrant
liabilities |
|
(152) |
|
903 |
Decrease (increase) in
accounts receivable |
|
531 |
|
(534) |
Decrease (increase) in other
current assets |
|
2,989 |
|
(1,346) |
Increase (decrease) in
accounts payable |
|
1,599 |
|
(350) |
Increase (decrease) in
deferred revenues |
|
213 |
|
(1,286) |
Decrease in accrued expenses
and other current liabilities |
|
(4,437) |
|
(4,034) |
Other |
|
(219) |
|
(155) |
Net cash provided by (used in)
operating activities |
|
11,704 |
|
(16,393) |
Cash flows from
investing activities: |
|
|
|
|
Purchases of marketable
securities |
|
(41,118) |
|
— |
Capitalized internal-use
software costs |
|
(5,443) |
|
— |
Other |
|
(171) |
|
(141) |
Net cash used in investing
activities |
|
(46,732) |
|
(141) |
Cash flows from
financing activities: |
|
|
|
|
Proceeds from exercise of
stock options |
|
2,010 |
|
2,707 |
Payments for employee taxes
withheld related to vested stock-based awards |
|
(3,195) |
|
(810) |
Repurchase and cancellation of
common stock |
|
(11,003) |
|
— |
Net cash (used in) provided by
financing activities |
|
(12,188) |
|
1,897 |
Net decrease in cash and cash
equivalents |
|
(47,216) |
|
(14,637) |
Cash and cash equivalents at
the beginning of the year |
|
123,908 |
|
138,545 |
Cash and cash equivalents at
the end of the year |
|
$76,692 |
|
$123,908 |
|
Non-GAAP Financial Measures
In addition to our financial results determined
in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP
measure, is useful in evaluating our operating performance, and our
management uses it as a key performance measure to assess our
operating performance. Because adjusted EBITDA facilitates internal
comparisons of our historical operating performance on a more
consistent basis, we use this measure for business planning
purposes and in evaluating acquisition opportunities. We also use
adjusted EBITDA to evaluate our ongoing operations and for internal
planning and forecasting purposes. We believe that this non-GAAP
financial measure, when taken together with the corresponding GAAP
financial measures, provides meaningful supplemental information
regarding our performance by excluding certain items that may not
be indicative of our business, results of operations or outlook. We
believe that the use of adjusted EBITDA is helpful to our investors
as it is a metric used by management in assessing the health of our
business and our operating performance. However, non-GAAP financial
information is presented for supplemental informational purposes
only, has limitations as an analytical tool and should not be
considered in isolation or as a substitute for financial
information presented in accordance with GAAP.
Some of the limitations of adjusted EBITDA
include (i) adjusted EBITDA does not necessarily reflect capital
commitments to be paid in the future and (ii) although depreciation
and amortization are non-cash charges, the underlying assets may
need to be replaced and adjusted EBITDA does not reflect these
requirements. In evaluating adjusted EBITDA, you should be aware
that in the future we will incur expenses similar to the
adjustments described herein. Our presentation of adjusted EBITDA
should not be construed as an inference that our future results
will be unaffected by these expenses or any unusual or
non-recurring items. Our adjusted EBITDA may not be comparable to
similarly titled measures of other companies because they may not
calculate adjusted EBITDA in the same manner as we calculate the
measure, limiting its usefulness as a comparative measure. Adjusted
EBITDA should not be considered as an alternative to income (loss)
before income taxes, net income (loss), income (loss) per share, or
any other performance measures derived in accordance with U.S.
GAAP. When evaluating our performance, you should consider adjusted
EBITDA alongside other financial performance measures, including
our net income (loss) and other GAAP results.
A reconciliation is provided below for adjusted
EBITDA to net income (loss), the most directly comparable financial
measure stated in accordance with GAAP. Investors are encouraged to
review our financial statements prepared in accordance with GAAP
and the reconciliation of our non-GAAP financial measure to its
most directly comparable GAAP financial measure, and not to rely on
any single financial measure to evaluate our business. We do not
provide a forward-looking reconciliation of adjusted EBITDA
guidance as the amount and significance of the reconciling items
required to develop meaningful comparable GAAP financial measures
cannot be estimated at this time without unreasonable efforts.
These reconciling items could be meaningful.
Adjusted EBITDA
We calculate adjusted EBITDA as net income
(loss) adjusted to exclude (i) depreciation and amortization, (ii)
interest and other expenses (income), net, (iii) tax benefit and
expense, (iv) stock-based compensation expense, and (v) certain
non-recurring expenses, where applicable.
Talkspace, Inc.Reconciliation of GAAP
Results to Non-GAAP Results(Unaudited) |
|
|
|
Three Months Ended December 31, |
|
Year Ended December 31, |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
(in thousands) |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$1,214 |
|
$(1,306) |
|
$1,148 |
|
$(19,182) |
Add: |
|
|
|
|
|
|
|
|
Depreciation and
amortization |
|
207 |
|
283 |
|
859 |
|
1,285 |
Financial (income), net |
|
(616) |
|
(1,330) |
|
(5,739) |
|
(4,245) |
Income tax (benefit)
expense |
|
(29) |
|
53 |
|
94 |
|
218 |
Stock-based compensation |
|
1,883 |
|
1,994 |
|
9,173 |
|
8,395 |
Non-recurring expenses |
|
— |
|
— |
|
1,427 |
|
— |
Adjusted EBITDA |
|
$2,659 |
|
$(306) |
|
$6,962 |
|
$(13,529) |
Talkspace (NASDAQ:TALK)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Talkspace (NASDAQ:TALK)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025